These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21741814)

  • 1. Impact of a transient instability of the ecstasy market on health concerns and drug use patterns in The Netherlands.
    Brunt TM; Niesink RJ; van den Brink W
    Int J Drug Policy; 2012 Mar; 23(2):134-40. PubMed ID: 21741814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Content of ecstasy in the Netherlands: 1993-2008.
    Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
    Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological content of tablets sold as "ecstasy": results from an online testing service.
    Tanner-Smith EE
    Drug Alcohol Depend; 2006 Jul; 83(3):247-54. PubMed ID: 16364567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Instability of the ecstasy market and a new kid on the block: mephedrone.
    Brunt TM; Poortman A; Niesink RJ; van den Brink W
    J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mCPP: an undesired addition to the ecstasy market.
    Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
    J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.
    Morefield KM; Keane M; Felgate P; White JM; Irvine RJ
    Addiction; 2011 Jul; 106(7):1293-300. PubMed ID: 21320226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of use and harm reduction practices of ecstasy users in Australia.
    Allott K; Redman J
    Drug Alcohol Depend; 2006 Apr; 82(2):168-76. PubMed ID: 16226850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male and female ecstasy users: differences in patterns of use, sleep quality and mental health outcomes.
    Ogeil RP; Rajaratnam SM; Broadbear JH
    Drug Alcohol Depend; 2013 Sep; 132(1-2):223-30. PubMed ID: 23453259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criminal involvement among young male ecstasy users.
    Hendrickson JC; Gerstein DR
    Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
    Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
    Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What's in a Name? Correlates of Ecstasy Users Knowing or Agreeing that Molly is Ecstasy/MDMA.
    Palamar JJ
    J Psychoactive Drugs; 2018; 50(1):88-93. PubMed ID: 28937933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA).
    Kalasinsky KS; Hugel J; Kish SJ
    J Forensic Sci; 2004 Sep; 49(5):1106-12. PubMed ID: 15461119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
    Parrott AC; Rodgers J; Buchanan T; Ling J; Heffernan T; Scholey AB
    Hum Psychopharmacol; 2006 Jul; 21(5):285-98. PubMed ID: 16856221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of ecstasy use and harms in Australia.
    Degenhardt L; Roxburgh A; Dunn M; Campbell G; Bruno R; Kinner SA; George J; Quinn B; White N; Topp L
    Neuropsychobiology; 2009; 60(3-4):176-87. PubMed ID: 19893334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.